Cerity Partners’s RxSight RXST Stock Holding History

Cerity Partners’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$267K	Buy	55,393 +30,518	+123%	+$184K	﹤0.01%	2872
2026 Q1	$153K	Buy	+24,875	New	+$207K	﹤0.01%	2947

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Cerity Partners's RXST Position: Q2 2026 in Review

Cerity Partners increased its RxSight (RXST) stake by 123% in Q2 2026, buying an estimated $184K and bringing the position to 55,393 shares worth $267K. The position accounts for ﹤0.01% of the portfolio, ranked #2872.

Cerity Partners first reported a position in RXST in Q1 2026 and has held it in 2 quarters since. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Cerity Partners held 55,393 shares of RxSight worth $267K as of Q2 2026.
Cerity Partners bought 30,518 RxSight shares in Q2 2026, an estimated $184K.
RxSight made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2872 holding.
Cerity Partners first reported a position in RxSight in Q1 2026 and has held it in 2 quarters since.
151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.